An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient
Riccardo Bruna(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Patriarca(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandra Valpreda(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Augusto B. Federici(University of Milan), Roberta Rolla(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Enrico Dosio(Fondazione Ricerca Molinette), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Umberto Dianzani(University of Turin)
Cited by 2
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
The coding genome of splenic marginal zone lymphoma: activation of <i>NOTCH2</i> and other pathways regulating marginal zone development
|The Journal of Experimental Medicine|2012|378